{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:08:45Z","timestamp":1783944525867,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clgc.2026.102564","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:50:33Z","timestamp":1776174633000},"page":"102564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond the Tumor: Exploring the Financial Toxicity of Non-Muscle Invasive Bladder Cancer in a Diverse, Urban Population"],"prefix":"10.1016","volume":"24","author":[{"given":"Julia","family":"Nadelmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrewe L.","family":"Baca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Labagnara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6367-2854","authenticated-orcid":false,"given":"Priya","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Sankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clgc.2026.102564_bib0001","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1158\/1055-9965.EPI-11-0650","article-title":"Economic burden of cancer in the United States: estimates, projections, and future research","volume":"20","author":"Yabroff","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clgc.2026.102564_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12682-013-0152-3","article-title":"Financial distress in cancer patients","volume":"11","author":"de Souza","year":"2013","journal-title":"J Med Person"},{"key":"10.1016\/j.clgc.2026.102564_bib0003","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cncr.29808","article-title":"Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors","volume":"122","author":"Kale","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2026.102564_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11764-013-0305-7","article-title":"Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, Canada","volume":"8","author":"de Oliviera","year":"2014","journal-title":"J Cancer Surviv Res Pract"},{"key":"10.1016\/j.clgc.2026.102564_bib0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","article-title":"Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors","volume":"34","author":"Yabroff","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.clgc.2026.102564_bib0006","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JOP.2013.001322","article-title":"Impact of financial burden of cancer on survivors\u2019 quality of life","volume":"10","author":"Fenn","year":"2014","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.clgc.2026.102564_bib0007","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/cncr.28262","article-title":"Are survivors who report cancer-related financial problems more likely to forgo or delay medical care?: cancer-related financial problems","volume":"119","author":"Kent","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2026.102564_bib0008","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience","volume":"18","author":"Zafar","year":"2013","journal-title":"The Oncologist"},{"key":"10.1016\/j.clgc.2026.102564_bib0009","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","article-title":"Financial insolvency as a risk factor for early mortality among patients with cancer","volume":"34","author":"Ramsey","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.clgc.2026.102564_bib0010","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1200\/JCO.2009.23.1183","article-title":"American Society of Clinical Oncology guidance statement: the cost of cancer care","volume":"27","author":"Meropol","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102564_bib0011","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.eururo.2024.12.002","article-title":"The financial burden of localized and metastatic bladder cancer","volume":"87","author":"Scilipoti","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2026.102564_bib0012","unstructured":"SEER Cancer Stat Facts: Bladder Cancer. National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html."},{"key":"10.1016\/j.clgc.2026.102564_bib0013","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/JU.0000000000001633","article-title":"Contemporary outcomes of patients with nonmuscle-invasive bladder cancer treated with bacillus calmette-gu\u00e9rin: implications for clinical trial design","volume":"205","author":"Matulay","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2026.102564_bib0014","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MOU.0000000000000078","article-title":"The burden of bladder cancer care: direct and indirect costs","volume":"24","author":"Mossanen","year":"2014","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.clgc.2026.102564_bib0015","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","article-title":"The health economics of bladder cancer: a comprehensive reviewof the published literature","volume":"21","author":"Botteman","year":"2003","journal-title":"PharmacoEconomics"},{"issue":"5","key":"10.1016\/j.clgc.2026.102564_bib0016","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.juro.2017.10.049","article-title":"Financial toxicity among patients with bladder cancer: reasons for delay in care and effect on quality of life","volume":"199","author":"Casilla-Lennon","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2026.102564_bib0017","unstructured":"U.S. Census Bureau, \u201cQuick Facts Bronx County, New York\u201d. https:\/\/www.census.gov\/quickfacts\/fact\/table\/bronxcountynewyork\/POP815223. Accessed January 30, 2025."},{"key":"10.1016\/j.clgc.2026.102564_bib0018","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2026.102564_bib0019","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: the COST measure","volume":"120","author":"de Souza","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2026.102564_bib0020","article-title":"Association of race with cancer-related financial toxicity [published correction appears in JCO Oncol Pract. 2022 May;18(5):412. doi: 10.1200\/OP.22.00175]","volume":"18","author":"Panzone","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10.1016\/j.clgc.2026.102564_bib0021","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jamaoto.2022.3755","article-title":"Association of household income at diagnosis with financial toxicity, health utility, and survival in patients with head and neck cancer","volume":"149","author":"Noel","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.clgc.2026.102564_bib0022","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1200\/JCO.2006.07.9111","article-title":"Cost of cancer care: the patient perspective","volume":"25","author":"Kim","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102564_bib0023","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2105\/AJPH.2020.305579","article-title":"Transportation barriers to health care in the United States: findings from the National Health Interview Survey, 1997-2017","volume":"110","author":"Wolfe","year":"2020","journal-title":"Am J Public Health"},{"issue":"12","key":"10.1016\/j.clgc.2026.102564_bib0024","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/jnci\/djac134","article-title":"Addressing transportation insecurity among patients with cancer","volume":"114","author":"Graboyes","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.clgc.2026.102564_bib0025","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s10900-013-9681-1","article-title":"Traveling towards disease: transportation barriers to health care access","volume":"38","author":"Syed","year":"2013","journal-title":"J Community Health"},{"key":"10.1016\/j.clgc.2026.102564_bib0026","unstructured":"Swanson K. Bronx officials call for Amtrak to answer for Metro-North expansion delays. Bronx Times. Accessed August 6, 2025. https:\/\/www.bxtimes.com\/bronx-officials-amtrak-metro-north-expansion-delays\/."},{"issue":"16","key":"10.1016\/j.clgc.2026.102564_bib0027","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.1002\/cam4.6351","article-title":"The many ``costs'' of transportation: examining what cancer caregivers experience as transportation obstacles","volume":"12","author":"Thomson","year":"2023","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.clgc.2026.102564_bib0028","first-page":"317","article-title":"Addressing transportation barriers in oncology: existing programs and new solutions","volume":"32","author":"Pringle","year":"2024","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2026.102564_bib0029","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/jrh.12637","article-title":"Interventions to address cancer-related financial toxicity: recommendations from the field","volume":"38","author":"Edward","year":"2022","journal-title":"J Rural Health"},{"issue":"1","key":"10.1016\/j.clgc.2026.102564_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","article-title":"Urinary biomarkers in bladder cancer: a review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102564_bib0031","article-title":"Association of financial burden with quality of life and mental health outcomes in patients with cancer","volume":"4","author":"Zhang","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:19:43Z","timestamp":1783941583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1558767326000649"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102564","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the Tumor: Exploring the Financial Toxicity of Non-Muscle Invasive Bladder Cancer in a Diverse, Urban Population","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102564"}}